Publications

(2022). Neoadjuvant Cemiplimab for Stage II to IV Cutaneous Squamous-Cell Carcinoma. New England Journal of Medicine.

Source Document DOI

(2019). Inhibition of Haspin kinase promotes cell-intrinsic and extrinsic anti-tumor activity.

Source Document

(2018). Eczema Tvecium.

Source Document Follow

(2018). Role of CDK7 in Melanoma.

Source Document Follow

(2017). A Complete Response in cSCC with Ipi/Nivo.

Source Document Follow